US Stock MarketDetailed Quotes
LBPH Longboard Pharmaceuticals
- 59.760
- -0.010-0.02%
Trading Nov 21 13:51 ET
2.33BMarket Cap-26560P/E (TTM)
59.800High59.760Low715.49KVolume59.770Open59.770Pre Close42.76MTurnover2.74%Turnover RatioLossP/E (Static)39.05MShares59.95052wk High8.48P/B1.56BFloat Cap3.60052wk Low--Dividend TTM26.14MShs Float59.950Historical High--Div YieldTTM0.07%Amplitude2.700Historical Low59.770Avg Price1Lot Size
About Longboard Pharmaceuticals Company
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.
Company Profile
SymbolLBPH
Company NameLongboard Pharmaceuticals
Listing DateMar 12, 2021
Issue Price16.00
Founded2020
CEOMr. Kevin R. Lind
MarketNASDAQ
Employees50
Fiscal Year Ends12-31
Address4275 Executive Square,Suite 950
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-619-592-9775
Company Executives
- Name
- Position
- Salary
- Kevin R. Lind
- Director, President and Chief Executive Officer
- 2.05M
- Dr. Randall E. Kaye,M.D.
- Executive Vice President and Chief Medical Officer
- 1.16M
- Brandi L. Roberts
- Principal Accounting Officer, Executive Vice President and Chief Financial Officer
- 1.03M
- Paul J. Sekhri
- Chairman of the Board
- 145.81K
- Casey C. Lynch
- Independent Director
- 112.80K
- Vincent E. Aurentz
- Independent Director
- 109.34K
- Phillip M. Schneider
- Independent Director
- 121.80K
- Dr. Corinne Le Goff, Pharm.D.
- Independent Director
- 114.81K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data